Bedell Cristin's Cayman Islands team have advised Ironshore Therapeutics Inc on its proposed acquisition by Collegium Pharmaceutical Inc for $525 million in cash with the potential for an additional $25 million commercial milestone payment.
Ironshore Therapeutics Inc – a long-standing client of Bedell Cristin – has reached a definitive agreement to be acquired by Nasdaq-listed Collegium as part of its strategic growth into neurology.
A Bedell Cristin team led by partner Joss Morris and including partners Laura Hatfield and Stephen Nelson and associate Kim Ebanks has advised on the Cayman Islands-law aspects of the transaction, working with onshore counsel Goodwin Procter LLP.
Joss said: "We are very pleased to have advised our client on this exciting transaction, and to have worked with our valued colleagues at Goodwin Procter LLP."
Location: Cayman Islands
